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the burden of submicroscopic and 
asymptomatic malaria in india 
revealed from epidemiology studies 
at three varied transmission sites in 
india
Anna Maria van eijk1, patrick L. Sutton1,8, Lalitha Ramanathapuram1,9, Steven A. Sullivan1, 
Deena Kanagaraj2, G. Sri Lakshmi priya2,3, Sangamithra Ravishankaran2, Aswin Asokan2, 
V. Sangeetha2, pavitra n. Rao1, Samuel c. Wassmer  1,10, nikunj tandel  4,11, Ankita patel4, 
nisha Desai4, Sandhya choubey5, Syed Zeeshan Ali5, punam Barla5, Rajashri Rani oraon5, 
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Malaria in india, while decreasing, remains a serious public health problem, and the contribution of 
submicroscopic and asymptomatic infections to its persistence is poorly understood. We conducted 
community surveys and clinic studies at three sites in India differing in their eco-epidemiologies: 
Chennai (Tamil Nadu), Nadiad (Gujarat), and Rourkela (Odisha), during 2012–2015. A total of 6,645 
subject blood samples were collected for Plasmodium diagnosis by microscopy and pcR, and an 
extensive clinical questionnaire completed. Malaria prevalence ranged from 3–8% by PCR in community 
surveys (24 infections in Chennai, 56 in Nadiad, 101 in Rourkela), with Plasmodium vivax dominating in 
Chennai (70.8%) and Nadiad (67.9%), and Plasmodium falciparum in Rourkela (77.3%). A proportional 
high burden of asymptomatic and submicroscopic infections was detected in community surveys in 
Chennai (71% and 71%, respectively, 17 infections for both) and Rourkela (64% and 31%, 65 and 31 
infections, respectively). In clinic studies, a proportional high burden of infections was identified as 
submicroscopic in Rourkela (45%, 42 infections) and Chennai (19%, 42 infections). In the community 
surveys, anemia and fever were significantly more common among microscopic than submicroscopic 
infections. Exploratory spatial analysis identified a number of potential malaria hotspots at all three 
sites. there is a considerable burden of submicroscopic and asymptomatic malaria in malarious regions 
in india, which may act as a reservoir with implications for malaria elimination strategies.
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Malaria remains a major public health burden in the south-east Asia region, and approximately 80% of malaria 
cases of the nine countries in this region occur in India1. As the seventh largest and second most populous coun-
try in the world, the subcontinent contributes nearly half of the global population at risk of Plasmodium vivax1. 
Malaria surveillance is primarily conducted by active case detection by accredited social health activists (ASHAs) 
and passive case detection at Primary Health Centres (PHCs), Community Health Centres (CHCs), or malaria 
clinics. These surveillance programs included over 120 million blood smear examinations in 2014, equivalent 
to sampling ~10% of the population2. Although blood smear microscopy remains the most common diagnostic 
method, the number of malaria rapid diagnostic tests (RDTs) supplied by local and regional manufacturers has 
more than doubled since 20102. Molecular methods such as polymerase chain reaction (PCR) are expensive and 
require sophisticated laboratory equipment, making them unfeasible for routine diagnosis.
India has joined other countries on the path to malaria elimination and has recently developed a five-year 
National Strategic Plan for Malaria Elimination in India 2017–2022, whose goal is to eliminate malaria in 
states with low level malaria (<1 annual parasite incidence) or bring states with higher levels of malaria to 
pre-elimination levels by 20223. The epidemiology of malaria in India is complex. Both P. falciparum and P. vivax 
can be present, with falciparum malaria tending to dominate in the eastern and northeastern provinces, and P. 
vivax in other parts of the country. Malaria elimination strategies in India will need to be fine-tuned according 
to the endemicity at the state and district levels. For this purpose, it is important to know the real burden of 
malaria, i.e., not only what is routinely detected, but also what is asymptomatic (infections in people who do not 
feel sick and so who do not visit a clinic for diagnosis or treatment), or below the level of detection of the current 
common diagnostic tools of microscopy (submicroscopic) or RDTs. Recent reviews have shown the importance 
of submicroscopic infections for both P. falciparum and P. vivax4,5, although studies from India are lacking. To 
understand the local epidemiology of malaria in India and the submicroscopic and asymptomatic burden fur-
ther, we conducted a series of cross-sectional and clinic-based epidemiology studies at three sites in India with 
different malaria endemicities as part of an International Center for Excellence for Malaria Research6. A better 
understanding of the epidemiology of malaria in India is critical for allocating resources and assessing the impact 
of malaria control efforts. Here we describe the prevalence of malaria, species of Plasmodium parasite, presence of 
submicroscopic and asymptomatic infections, and identify hotspots, as well as assess the factors associated with 
malaria for each setting.
Results
characteristics of the study populations. Our three study sites were chosen because of their differ-
ent eco-epidemiologies: Chennai, in the southern state of Tamil Nadu; Nadiad in the western state of Gujarat,; 
and Rourkela in the eastern state of Odisha (Fig. 1). We conducted two different types of epidemiology study: 
cross-sectional surveys in the communities, which enrolled 928 subjects in Chennai, 796 subjects in Nadiad, and 
1,307 subjects in Rourkela (Table 1), and studies at local malaria clinics, which enrolled 1,054 subjects in Chennai, 
685 subjects in Nadiad, and 1,875 subjects in Rourkela. After enrolment of all 6,645 participants, a detailed clin-
ical questionnaire was completed, and a blood sample collected for Plasmodium diagnosis by microscopy, rapid 
Figure 1. Location of three study sites in India. The inset shows a global map of malaria endemicity as annual 
parasite incidence (API), adapted from the Malaria MAP Project. The three study sites are indicated in the west, 
east and south of India.
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diagnostic test (RDT), and PCR, and for testing of hemoglobin level. The study populations enrolled at the three 
sites differed in their characteristics (Table 1), e.g., males were more likely to take part in clinic studies compared 
to the community surveys; in the Rourkela site there were more participants <15 years, and of lowest educational 
level compared to the other sites. Anemia was common among participants (35.4%, 62.5%, and 48.8% of partici-
pants in community surveys in Chennai, Nadiad and Rourkela, respectively).
Malaria prevalence and symptomatic infections in the community surveys. We found the malaria 
prevalence (measured by PCR, weighted by gender and age) in our community surveys to be 2.7% in Chennai, 
7.5% in Nadiad, and 8.3% in Rourkela (Fig. 2), with P. falciparum the dominant species in Rourkela and P. vivax 
more common at the other sites. Risk factors identified for malaria (using generalized linear regression with a 
log link and binomial distribution) included (1) rainy season (as measured by PCR and microscopy) at all sites 
(Supplemental Table S2 and Fig. S2), and (2) male gender, associated with P. falciparum (detected by PCR) in 
Chennai and Rourkela (Supplemental Table S2). In Rourkela, where 30.1% of enrolled participants were <15 
years old, P. vivax diagnosed by PCR was more common among children <5 years old, whereas P. falciparum 
was more common in the age group 5–14 years of age compared to persons ≥15 years (Supplemental Table S2).
High burden of asymptomatic and submicroscopic infections in the community survey. We 
found that asymptomatic infections detected by PCR made up 70.8% of all malaria infections in Chennai (n = 17 
asymptomatic infections, 2 (11.8%) microscopic and 15 or 88.2% submicroscopic), 64.4% of all malaria infections 
in Rourkela (n = 65 asymptomatic infections, 38 or 58.5% microscopic and 27 or 41.5% submicroscopic), and 
21.4% of all malaria infections in Nadiad (n = 12 asymptomatic infections, all microscopic; Fig. 2). Symptomatic 
P. falciparum infections had significantly higher parasite densities compared to asymptomatic infections in 
Rourkela; no such differences were detected for the other sites (although numbers were low; Supplemental 
Table S3). Asymptomatic P. falciparum infections were more common among males in Chennai, whereas recent 
Community surveys (weighted by age and gender) Clinic studies
Chennai
% or mean  
(95% CI)
Nadiad
% or mean
 (95% CI)
Rourkela
% or mean (95% 
CI)
Chennai
% or mean (95% 
CI)
Nadiad
% or mean (95% 
CI)
Rourkela
% or mean (95% 
CI)
Number of 
participants 928 796 1307 1054 685 1875
Time period Dec 12-Oct 14 May 13-Sept 14 Jan 13-Sep 14 Apr 12-Mar 15 Jan 13-Apr 15 Apr 12-Apr 15
Median age, 
interquartile range 29.0, 17.0–43.0 30.0, 17.0–45.0 25.0, 12.0–40.0 30.0, 21.0–42.0 25.0, 13.0–40.0 28.0, 12.0–43.0
Age groups (%)
<5 years 6.3 (4.3–9.2) 5.4 (3.5–8.3) 8.8 (7.5–10.3)* 0.9 (0.5–1.8) 3.8 (2.6–5.5) 8.6 (7.4–10.0)†
5–14 years 14.0 (11.7–16.7) 15.4 (13.0–18.1) 21.3 (19.3–23.5) 7.7 (6.2–9.5) 23.1 (20.1–26.4) 20.8 (19.0–22.7)
15+ years 79.7 (76.3–82.7) 79.2 (75.8–82.2) 69.9 (67.5–72.2) 91.4 (89.5–92.9) 73.1 (69.7–76.3) 70.6 (68.5–72.6)
Male 50.4 (46.7–54.0) 51.6 (48.0–55.2) 50.5 (47.8–53.2) 68.0 (65.1–70.8)‡ 60.4 (56.7–64.0) 57.4 (55.1–59.6)
History and 
symptoms
Documented fever 3.4 (2.4–4.9)‡ 6.1 (4.7–8.0) 7.7 (6.5–9.2) 34.1 (31.3–37.0)** 29.1 (25.8–32.6) 32.6 (30.5–34.8)
History of fever last 
2 days 10.9 (8.7–13.7) 22.4 (19.6–25.5) 7.4 (6.2–8.8)
† 95.0 (93.5–96.1) 67.4 (63.8–70.9) 93.0 (91.7–94.0)†
History of fever or 
documented fever 11.3 (9.0–14.1) 24.5 (21.6–27.7)
§ 12.4 (10.8–14.1) 96.0 (94.6–97.0) 77.8 (74.5–80.8) 94.1 (93.0–95.1)†
History of malaria 
last year 5.9 (4.5–7.6) 4.6 (3.1–6.7) 25.9 (23.6–28.2)* 16.6 (14.5–19.0)
‡ 7.3 (5.6–9.5) 6.7 (5.6–7.9)
History of travel past 
2 wks 12.5 (10.3–15.1) 11.1 (9.0–13.7) 2.6 (1.9–3.6)* 16.4 (14.3–18.8) 13.6 (11.2–16.4) 23.7 (21.8–25.6)*
Antimalarial use past 
2 wks 0.3 (0.1–0.8) 5.7 (4.2–7.7) 1.6 (1.1–2.4)
† 2.3 (1.6–3.4) 0.6 (0.2–1.6)§ 2.5 (1.8–3.3)
Use of ITNs 0 0.6 (0.3–1.5) 28.4 (26.2–30.9)† 0 0 0.1 (0.0–0.4)
Use of repellents†† 45.6 (42.0–49.4) 39.5 (36.1–43.1) 32.5 (29.8–35.3)† 33.7 (30.9–36.6) 50.2 (46.5–54.0) 77.9 (76.0–79.7)†
Anemia (%)‡‡ 35.4 (32.2–38.8) 62.5 (59.0–65.9) 48.8 (46.0–51.7)† 26.5 (23.9–29.2) 54.4 (50.6–58.1) 36.1 (33.9–38.3)†
Table 1. Characteristics of participants by location and type of study at three study sites in India, 2012–2015. 
CI: confidence interval, ITN: insecticide treated net (long lasting insecticide treated net or a net treated within 
the last 6 months), wks: weeks. *P < 0.05 comparing Rourkela to Chennai and Nadiad. †P < 0.05 comparing to 
each other. ‡P < 0.05 comparing Chennai to Nadiad and Rourkela. §P < 0.05 comparing Nadiad to Chennai and 
Rourkela. **P < 0.05 comparing Chennai to Nadiad. ††Repellents include the use of coils, vaporizers, mats or 
creams for the prevention of mosquito annoyance. ‡‡Age and gender appropriate definition: Hemoglobin < 11 g/
dl if age < 5 years, <11.5 g/dl if age ≥ 5 and <12 years, <12 g/dl if age > 12 and age < 15, <12 g/dl if age ≥ 15 
and female, and <13 g/dl if ≥15 and male.
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antimalarial use and travel were associated with asymptomatic P. vivax in Nadiad (Supplemental Table S2). In 
Rourkela, asymptomatic infections were significantly more common for P. vivax compared to P. falciparum 
(85.4% vs. 62.0%, P = 0.034). Additionally, asymptomatic P. falciparum infections were associated with the rainy 
season, being male, and ITN (insecticide treated net) use, and asymptomatic P. vivax infections with repellent 
(protective) and recent antimalarial use (Supplemental Table S2).
Similarly, submicroscopic infections were detected in 70.8% of the cases in Chennai (17 infections), and 30.7% 
of the cases in Rourkela (31 infections), although they were not species-specific (Fig. 2; in Nadiad, all but two 
Plasmodium infections were detected by microscopy). Submicroscopic P. falciparum infections were more com-
mon among males at both sites, and submicroscopic P. vivax infections were associated with the rainy season and 
age <15 years compared to age ≥15 years in Rourkela (Supplemental Table S2).
Figure 2. Malaria at three sites in India, 2012–2015. (A) Malaria in community surveys and clinic studies at the 
three sites. *The first percentages in the columns are the percentages of malaria (weighted by age and gender 
for the community surveys); the numbers after the percentages indicate the absolute number of infections in 
the group, and those in brackets represent the percentage in this group of all infections. Symptomatic malaria 
was defined as documented fever (a body temperature ≥37.5 °C) or a history of fever in the past 48 hours. (B) 
Symptomatic and asymptomatic malaria infections as percentages (weighted for age and sex) in community 
surveys at the three sites. For actual numbers and Plasmodium species, see Supplemental Table S1.
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Effects of type of malaria infections in the community studies are reported in Fig. 3. First, malaria infections 
overall and P. falciparum infections detected by microscopy were typically associated with symptoms of fever, 
compared to persons without malaria as determined by PCR or microscopy, in contrast to submicroscopic infec-
tions (Fig. 3A); a similar pattern was seen for anemia (Fig. 3B). Second, the effect of symptomatic and asympto-
matic malaria on anemia differed by site, with asymptomatic infections and symptomatic malaria associated with 
increased risk of anemia compared to no malaria in Nadiad, and only symptomatic malaria a risk factor for ane-
mia in Rourkela (Fig. 3C). Finally, there was no significant difference in proportion of gametocytaemia compar-
ing symptomatic versus asymptomatic P. falciparum infections, although in Rourkela they were more common 
among asymptomatic infections (5/54 vs. 2/37 in symptomatic infections, Supplemental Table S3). The majority 
of P. vivax infections contained gametocytes as determined by microscopy, except for in Rourkela (Supplemental 
Table S3).
Mixed Plasmodium species infections were rare. We detected very few mixed P. vivax and P. fal-
ciparum infections across the community studies by PCR: one in Chennai, two in Nadiad and 5 in Rourkela 
(Supplemental Table S1). Mixed infections were more common in participants <15 years (6/627 [1%] vs. 2/2407 
among ≥15 years [0.08%], Fisher’s exact test P = 0.001) in the community studies, but they were not more likely 
to be symptomatic compared to infections with one species (2/8 [25.0%] vs. 85/173 [49.1%], P = 0.182). Across 
the community surveys, participants with P. falciparum infections were almost four times more likely to be diag-
nosed with an additional P. vivax infection compared to persons without a P. falciparum infection (pooled prev-
alence ratio unweighted data 3.80, 95% CI 1.84–7.83, I2 0%; Supplemental Fig. S4).
Exploratory Spatial Data Analysis reveals malaria hot-spots in community studies. Using 
Exploratory Spatial Data Analysis (ESDA)7, we determined the presence, strength, and direction of spatial auto-
correlation globally (across the entire dataset) and locally (within the immediate surroundings of each data 
point), of Plasmodium infections identified by PCR in the community studies. Global and Local Moran’s I anal-
yses identified areas where greater concentrations of malaria occurred than would be expected from a random 
distribution of cases (Fig. 4). The Chennai (Fig. 4A), Nadiad (Fig. 4B) and Rourkela (Fig. 4C) sites exhibited 
I values of −0.008 (p = 0.2253), 0.125 (p = 0.0014), and 0.049 (p = 0.0002) respectively (pseudo-significance p 
Figure 3. Associations between malaria and fever or anemia at three sites in India, 2012–2015. When a 
study site was not included, the site did not have enough information for this analysis. (A) The association 
between fever and microscopic/submicroscopic malaria from community surveys. Chennai not included: 
only one person with microscopic symptomatic P. falciparum infection, and six persons with submicroscopic 
asymptomatic P. falciparum infections (0 symptomatic submicroscopic persons). Nadiad not included: 
two persons with submicroscopic symptomatic malaria infections (1 P. falciparum and 1 P. vivax), 0 with 
asymptomatic malaria. Fever defined as a history of fever in the past 48 hours or documented fever (≥37.5 °C), 
malaria parasites detected by PCR. (B) The association between anemia and microscopic/submicroscopic 
malaria from community surveys. Chennai not included: only 1 person with microscopic malaria (P. 
falciparum) without anemia; Nadiad not included; only 1 person with submicroscopic malaria (P. falciparum) 
with anemia. (C) The association between anemia and symptomatic and asymptomatic malaria from 
community surveys. Chennai not included: only one person with symptomatic P. falciparum infection without 
anemia.
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values simulated using 9999 random permutations), indicating that Nadiad and Rourkela exhibit overall cluster-
ing (significant at the 5% level), whereas Chennai exhibited overall dispersal (not significant at the 5% level). This 
is notable because a vector-borne disease such as malaria typically would be expected to exhibit a strong clustered 
autocorrelation due to the spatial relationships between cases and the transmission of the parasite by Anopheles 
mosquito8.
Since local patterns may exist even if not evident across a dataset7, a single illustrative site was characterized 
further from each of the locations. In Chennai (Fig. 4A), two positive clusters (significant to the 5% level) were 
identified from 887 georeferenced PCR results in an area of 0.046 km2. The hotspots for these clusters overlapped 
entirely and provide a single area of interest (AOI) for further investigation, comprising an area known for hous-
ing fishermen in close proximity to the Besant Nagar beach. In Nadiad (Fig. 4B), four positive clusters (significant 
to the 5% level) were identified from 409 georeferenced PCR results. The hotspot polygons derived from the 
respective neighbourhoods of these clusters also overlapped, with three aligning perfectly in an area of 0.383 km2, 
and the fourth overlapping partially with an area of 0.503 km2. This delineated a single large AOI containing 
tightly packed high-rise housing interspersed with commercial buildings. Finally, in Rourkela (Fig. 4C), twelve 
positive clusters (significant to the 5% level) ranging in area from 0.456 km2 to 0.761 km2 were identified from 652 
georeferenced PCR results. Again, the hotspot polygons overlapped to form a single AOI, encompassing a small 
number of rural dwellings in close proximity to forest, located either along roads or in small clusters, and two 
large areas of scrubland and several fields that exist between groups of settlements.
Malaria and risk in clinic studies. In our clinic studies (passive case detection), malaria prevalence as 
detected by PCR was 21.1% (222 infections) in Chennai, 9.6% (66 infections) in Nadiad, and 5.0% (93 infections) 
in Rourkela; submicroscopic infections were 18.9% (42 infections) in Chennai, 1.5% (1 infection) in Nadiad, and 
45.2% (42 infections) in Rourkela of the total malaria detected (Fig. 2). Common risk factors for malaria included 
being male, the rainy season, and a history of malaria in the past year (Supplemental Table S4). Although malaria 
by PCR overall was associated with anemia (pooled estimate 1.41, 95% CI 1.11–1.80 for any species) by site and 
species, this was only significant for microscopic P. falciparum in Nadiad, and for P. vivax in Chennai, and not for 
submicroscopic malaria (Supplemental Fig. S3).
Discussion
To gain an understanding of the local epidemiology and burden of malaria in India, we conducted active and pas-
sive case detection studies in community and clinic settings at three sites. In the community (i.e., active) surveys, 
the point prevalence was low in all sites, with P. vivax dominating in Chennai and Nadiad, and P. falciparum in 
Rourkela, confirming the species distribution historically reported. In Chennai the majority of infections were 
submicroscopic (17 or 70.8%) and asymptomatic (17 or 70.8%), and similarly in Rourkela most infections were 
asymptomatic (65 or 64.4%) and 31 (35.6%) were not detected by microscopy. In contrast, Nadiad subjects that 
were asymptomatic (12 or 21.4%) or submicroscopic (2 or 3.6%) constituted only a minority of infections detected 
Figure 4. Examples of positive clusters of Plasmodium infections in community studies identified by PCR 
at sites in (A) Chennai, (B) Nadiad and (C) Rourkela. The LISA classification (positive or negative cluster or 
outlier) of each point is shown, and refers to the neighbourhood around each point, and not simply to the 
individual point. Red neighbourhood polygons (convex hulls constructed around all of the neighbours of a 
given point) are shown for each significant positive cluster and mark the maximum enclosing boundary of 
the ‘positive hotspot’ of Plasmodium infection, representing an area of interest (AOI) for further investigation. 
Satellite Imagery via Google Maps. Imagery © 2018 VNES/Airbus, Digital Globe, Landsat/Copernicus.
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by community surveys. In our clinic studies, the majority of malaria infections were detectable by microscopy. 
However, approximately one in five infections in Chennai and two in five infections in Rourkela were submi-
croscopic, with troubling implications for malaria treatment and reservoirs of transmission. Moreover, just like 
symptomatic infections, asymptomatic infections detected in the community survey in Nadiad were associated 
with a significantly increased risk of anemia compared to persons without Plasmodium infections.
Very few surveys in India have used molecular methods such as PCR to assess the submicroscopic burden of 
malaria, and in those cases (as in our study) the results were variable and dependent upon the setting. For exam-
ple, a survey in June 2012 in Purulia district, West Bengal, identified 6.9% P. falciparum infections by microscopy, 
8.1% P. falciparum infections by PCR, and 1.2% submicroscopic infections9 among 963 participants; whereas a 
survey in the low transmission season of 2014 among 133 persons using insecticide treated nets in Missamari, 
Assam, detected no infections by PCR, microscopy, or rapid diagnostic test10. A study in 2007–2008 among preg-
nant women in Chhattisgarh, a state neighbouring Odisha, noted that the majority of infections detected in the 
antenatal clinic and in the placenta at delivery were submicroscopic (antenatal clinic 3.4% by PCR, 70.6% submi-
croscopic; placenta 4.2% by PCR, 73.8% submicroscopic), but no association with anemia was detected11. In three 
villages in Chhattisgarh, a survey in 2016 during the low transmission season detected 10% subpatent and 18% 
asymptomatic malaria12. A high submicroscopic or asymptomatic burden has been reported in studies elsewhere 
in Asia4,13,14; and a recent study in three southeast Asian countries found four times higher prevalence of submi-
croscopic Plasmodium infections with a sensitive PCR method compared with microscopy, indicating that the 
burden may still be underestimated15. We could retrieve few studies reporting on the effects of submicroscopic 
malaria from areas with both malaria parasite species: in Brazil, submicroscopic P. vivax was associated with 
anemia16, but this association was not seen in our studies, or in a study in Indonesia13.
In our community surveys, age was a risk factor for malaria mainly in Rourkela, the site with the highest 
prevalence of P. falciparum; compared to adults, young children (<5 years) were significantly more likely to have 
microscopic P. falciparum and microscopic and submicroscopic P. vivax, whereas older children (5–14 years) 
were more at risk for P. falciparum. In areas with multiple malaria parasite species, it has been suggested that 
the acquisition of immunity to P. vivax develops faster, with a peak of P. vivax at younger ages compared to P. 
falciparum, and an earlier ability to keep parasite densities of P. vivax infections under control17,18. Age patterns 
similar to our observations have been described in studies from Bangladesh, Papua New Guinea, Thailand, and 
the Amazon in Brazil16,19–21. The reasons for the faster acquisition of clinical immunity to P. vivax are not well 
understood, but repeated exposures from hypnozoites might be a contributing factor22,23.
Males were at higher risk of malaria at all of our sites. The difference in malaria risk by gender among adults 
has been reported before in Asia15,24 and Ethiopia25, and has been attributed to more outdoor activity by men 
in areas, such as forests, with infected mosquitoes. However, the increased risk was also observed in our site in 
the urban city of Chennai that has few forested areas. This higher risk might be due to different use of malaria 
prevention methods, distinctive attractiveness to mosquitoes, different travel patterns by gender, or hormonal or 
host-genetic factors24. A better understanding of the factors contributing to the gender gap may assist in identify-
ing more efficient ways to prevent malaria among males, by determining, e.g., if the increased risk among males 
is exposure-related on account of different habits before bed time compared to women.
Other risk factors for malaria included travel for P. vivax in the community surveys in Chennai and Nadiad, 
perhaps indicating that not all malaria detected in these locations originated at those sites. Although ITNs were 
only used in Rourkela, they were more a marker of malaria risk than associated with protection, as has been previ-
ously reported26, whereas the use of repellents was associated with reduced malaria risk in Nadiad and Rourkela.
At our site in Nadiad, almost all infections in the clinic study and community survey were microscopic. 
Nadiad has a history of low malaria prevalence, so residents can be expected to have low immunity, which may 
explain why most infections will develop parasitaemias detectable by microscopy. However, even in this area with 
sustained low transmission, one out of five malaria infections identified in the community surveys was asymp-
tomatic. A review of submicroscopic P. falciparum infections suggested that submicroscopic carriers actually 
predominate in areas of lower transmission, which would accord with our observations at our other sites27.
Several factors have been associated with submicroscopic and asymptomatic Plasmodium infections. Recent 
use of an antimalarial drug can reduce Plasmodium infections to submicroscopic levels as part of the normal 
process of clearing parasites. However, persistence of submicroscopic levels can occur after treatment when drug 
resistance is present or when inadequate doses of antimalarials are used. In areas with both P. vivax and P. falci-
parum, treatment of P. falciparum or mixed species infections has been associated with an increased risk of the 
occurrence of P. vivax28. Recent antimalarial use was associated with symptomatic and asymptomatic P. vivax 
infections in community studies in Nadiad and symptomatic P. vivax in community studies in Rourkela, and 
with submicroscopic malaria in clinic studies in Chennai. P. falciparum resistance to chloroquine is well known, 
but P. vivax resistance to chloroquine has been infrequently reported in India29,30; currently the combination 
artesunate-sulfadoxine-pyrimethamine is used with good reported efficacy in our study sites31.
Although it has been suggested that mixed species infections may be more commonly detected by PCR com-
pared to microscopy32, we did not find a large discrepancy in number detected by the two methods (Supplemental 
Table S1). While mixed species infections were more common than would be expected from the prevalence of 
single infections in our community surveys, their overall prevalence was low, in accord with other reports from 
surveys in Asia (Supplemental Table S5). It has been suggested that one species may suppress another, or that mul-
tiple species in a region may attenuate clinical disease33. Mixed infections were too rare in our study to support 
meaningful analysis, but patterns of malaria prevalence by age, gender, and species in Rourkela indirectly show 
that immunity development is different for both species (Supplemental Table S1).
Our spatial data analysis demonstrated how local spatial autocorrelation techniques on high resolution (indi-
vidually georeferenced) datasets can be used to identify specific areas of interest (AOIs) in which there are unex-
pectedly high concentrations of Plasmodium infections. Though there has been a great deal of interest in the 
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application of autocorrelation and other spatial analysis techniques (‘spatial epidemiology’34) in the literature in 
recent years, leading to substantial improvements in risk mapping for malaria and other diseases such as den-
gue8,35,36, this work has almost exclusively been undertaken using historical data that have been aggregated to the 
district or village level (e.g.7,8,34). In contrast to this, our analysis of individually georeferenced PCR results allowed 
analysis to take place without the generalisation and aggregation that are typically exhibited in datasets relating 
to disease prevalence. Accordingly, specific AOIs have been identified for further analysis, rather than simply the 
district within which hotspots are contained. Once identified, AOIs can undergo further scrutiny either statisti-
cally, using techniques such as Geographically Weighted Regression in order to examine the relationship between 
hotspots and social, entomological, or environmental factors; or in the field, by visiting the locality in order to 
identify behaviours or factors that may be contributing to these hotspots, and propose interventions in order to 
reduce risk. Additional collection of temporal data too will enable changes in risk factors, malaria incidence, and 
the resulting autocorrelation results over time to be discerned, as reported by other studies35,36.
Our study had several limitations. First, factors which can contribute to the detection of submicroscopic infec-
tions include the skill of the microscopist, the quality of the PCR reaction, the amount of genetic material used 
for PCR, and host and parasite factors4. The microscopists at our sites were trained and experienced, and the PCR 
tests were were performed by experienced molecular biology technicians at each site and repeated at least twice 
with cross-checking of a subset in a second lab. Parasite genetic diversity may affect submicroscopic infections 
and this is still under study at our sites, and associations between other host genetic factors such as hemoglo-
binopathies were not examined. We did not determine if persons identified with asymptomatic infections sub-
sequently developed symptoms, or if they were able to clear the parasites. The surveys in Chennai and Rourkela 
were underpowered and it is possible that some associations with malaria were not significant because of low 
numbers. Second, because of the timing of the interviews during the daytime, our surveys did not capture all 
household members; in Nadiad and Chennai, men and children were underrepresented compared to the census 
(Supplemental Fig, S1), and this may have lead to an underestimation of the real malaria prevalence if children 
and men are more at risk of malaria. While logistically challenging, undertaking interviews early in the morning 
or later in the afternoon and on weekends to capture all household members may be a better approach in future 
studies.
In summary, although the overall burden of malaria at our three sites in India was low, the contribution of 
submicroscopic infections (range 3–74%) and of asymptomatic infections (range 18–74%) should not be under-
estimated in light of malaria elimination efforts. This is especially true for P. vivax, where hypnozoites, a source 
of recurrent infections, are unlikely to be treated if the infection is not identified. In addition, the gametocytes 
of P. vivax in asymptomatic infections have been shown to be as infectious as in symptomatic malaria37 and 
P. falciparum gametocytes can be as common or more prevalent in asymptomatic compared to symptomatic 
infections38. In malaria clinics, submicroscopic infections are of concern because patients may not receive the 
treatment they need. Since molecular methods such as PCR are not suitable for routine use as a diagnostic in 
a health care setting due to the costs, training, and equipment involved, ultra-sensitive point-of-care tools are 
urgently needed39.
Methods
Study sites and population. Chennai city, the capital of the southern state of Tamil Nadu and the sixth 
most populous city with ~7 million people, is located on the coast of the Bay of Bengal. The main rainfall period 
is from October-December as part of the northeast monsoon, but rains also fall during the southwest mon-
soon between July-August40. Malaria transmission (predominantly P. vivax) in Chennai is perennial and peaks 
between July-October. The Besant Nagar Malaria Clinic is in a predominantly residential neighbourhood com-
posed of middle- and upper-class dwellings, along with a few slums and a large coastal fishing community. 
Subjects were enrolled from the Besant Nagar Malaria Clinic and the surrounding Besant Nagar catchment area. 
Nadiad city, population ~225,000, is located in the district of Kheda in the central part of Gujarat State. Nadiad 
receives the majority of its rain during the southwest monsoon season (June-September)40. Malaria is considered 
to be unstable (hypo-endemic), with P. vivax and P. falciparum prevalence rates oscillating throughout the year 
based on the rainfall. The National Institute of Malaria Research (NIMR) Malaria Clinic is located in the Civil 
Hospital of Nadiad in a predominantly residential neighbourhood. Subjects were enrolled at the Civil Hospital 
outpatient clinic, and community surveys were conducted in areas adjacent to Nadiad town. Rourkela city, popu-
lation ~483,000, is located in the Sundargarh district of the eastern state of Odisha. Rourkela receives rains during 
the southwest monsoon season (June-September) and some rainfall during the northeast monsoon (December-
January)40. Historically, malaria transmission has been meso- to hyper-endemic in this region, with P. falciparum 
as the major infecting species, accounting for >40% of the total cases in the country. Subjects were enrolled from 
a malaria clinic at Sector 1 in Rourkela, whereas community surveys were conducted in areas close to forested 
regions around Rourkela.
Study designs. A clinic study and community surveys were conducted in each setting. For the clinic 
studies, symptomatic subjects aged 12 months to 69 years who self-presented with complaints of illness 
to the clinic for malaria testing were eligible for enrollment, while pregnant women were excluded; a con-
venience sample was used. After consent, individuals underwent a physical examination, were asked ques-
tions about their history of malaria, and had finger-prick blood collected for hemoglobin measurement, 
blood smear, and PCR. Persons with a positive malaria test in the clinic were treated as per national guide-
lines; treatment was not directly observed (P. vivax: chloroquine 25 mg/kg over three days and primaquine 
0.25 mg/kg for 14 days; P. falciparum artesunate 4 mg/kg for 3 days in combination with sulfadoxine 25 mg/
kg and pyrimethamine 1.25 mg/kg on the first day and primaquine 0.75 mg/kg)41. A census was conducted 
before the start of the community surveys. The community surveys were conducted in random household 
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samples of the census and were conducted over the course of two years spread around the seasons; If a 
household was not available, the next household on the list was used. All members available in the house-
hold were sampled during day time hours of 7AM to 3 PM. We did not return to a household to find missing 
household members. Compared to the census, children were under-represented in Chennai and Nadiad, 
whereas women were overpresented in all sites (Supplemental Fig. S1). The latitude and longitude of each 
household was taken using a handheld GPS device. Procedures and exclusion criteria were the same as for 
the studies in the clinics. For the surveys, sample sizes were estimated based on a two-tailed, point biserial 
model with a conservative 95% confidence interval and a power ≥90% (G*Power v3.1.2) for a range of 
prevalences; for Chennai, the prevalence was expected to be around 12–16% with estimated sample sizes of 
459–950, in Nadiad the expected prevalence range was 7–11% with estimated sample sizes of 780–2000, and 
corresponding numbers in Rourkela were 19–26% and estimated sample size of 109–355. The surveys aimed 
for 400 participants every 3 months (per site), but because of logistical constraints (availability of staff, poor 
weather conditions) this was not always feasible.
Diagnostic methods. Hemoglobin level was assessed using HemoCue (Ängelholm, Sweden). Thin and 
thick smears were Giemsa stained and at least 300 fields in the thick smear were examined by microscopy 
using a 100x oil immersion objective. Parasites were counted on the thick smear against 200–500 leucocytes. 
The results were expressed as parasites per microliter of blood, using the white blood cell (WBC) count if 
known, or assuming 8,000 WBCs per microliter of blood. Slides were routinely read by two microscopists, 
and a third microscopist was used if there was disagreement. All samples, whether positive or negative by 
microscopy, underwent DNA extraction by QIAamp DNA blood Mini Kits (Qiagen Inc., Valencia, CA). 
A modified nested, multiplex-PCR method targeting the 18 S small subunit ribosomal DNA gene (SSU 
rDNA) was used for species-specific detection of Plasmodium parasites42,43. Amplicons were visualized on a 
1.5% agarose gel, and fragment sizes determined using a 100 bp DNA ladder (exACT gene, Thermo Fisher 
Scientific, Pittsburg, PA). All samples were amplified by PCR at least twice, and a third time if any discrep-
ancy, and 10% sent for cross-checking at a central lab facility. Positive controls consisting of known P. fal-
ciparum, P. vivax and P. malariae DNA and negative controls (no DNA) were used for every amplification 
experiment.
Analysis. A secure, web-based REDCap (Research Electronic Data Capture) database was used to capture 
and store all subject data and test results44, and data were exported into Stata (Stata/IC version 14.2, StataCorp 
LP, College Station, USA) for analysis. We classified parasite infections detected by PCR but not by microscopy 
as ‘submicroscopic’. We defined malaria as symptomatic if the subject was Plasmodium-positive by PCR and had 
documented fever (a body temperature of ≥37.5 °C) or a history of fever in the past 48 hours. For anemia, an age- 
and gender-appropriate definition was used45: <11 g/dl if <5 years, <11.5 g/dl if 5–11 years, <12 g/dl if 12–14 
years or >15 years and female,<13 g/dl if male and >15 years. In all three study areas, risk factors for submicro-
scopic and asymptomatic malaria were examined among community survey participants, and for submicroscopic 
malaria among clinic participants. Risk factors included those known from literature, such as age, gender, a his-
tory of travel in the past two weeks, a history of malaria in the past year, antimalarial use in the past two weeks, 
reported use of repellents (coils, vaporizers), and season at the time of visit. Generalized linear regression with 
a log link and binomial distribution was used for multivariate analyses, and Poisson regression with a robust 
variance estimator was used for models which did not converge46. Factors with a p-value < 0.15 in the univariate 
model were included in the multivariate model, and factors with a p-value > 0.08 were removed from the multi-
variate model. All community survey analyses were weighted by age and gender, using the household information 
obtained from the census (svy procedure in Stata 14.2). To assess a potential effect of malaria infections on fever 
and anemia, we combined the data in forest plots using fever and anemia among persons without malaria by PCR 
as the reference group (random effects model); the I2 was used as an indicator of heterogeneity between studies.
exploratory spatial data analysis. We used Exploratory Spatial Data Analysis (ESDA)7 to visualize spa-
tial distributions of a subset of 3,001 subjects enrolled in the community studies at Chennai (n = 907), Rourkela 
(n = 1306) and Nadiad (n = 788). Local Indicators of Spatial Association (LISA) were calculated using Local 
Moran’s I analysis47, operationalized using the PySAL library for Python (https://pysal.readthedocs.io/en/latest/). 
As with similar spatial analysis techniques (e.g. Gi and Gi*48), Moran’s I may be used to test the null hypothesis of 
no local spatial association. Pseudo-significance levels were calculated using 9999 random permutations of the 
analysis. We constructed a ‘spatial weights’ matrix, containing a representation of the neighbourhood structure 
of the study area and containing all of the points that fall within a certain distance threshold of another point, 
referred to as the ‘neighbours’ for that point, with each value representing a standardised distance between the 
points. This approach minimises sensitivity to variations in the distance threshold because closer points are more 
important than those further away. For the purposes of this analysis, the threshold at each site is calculated as the 
smallest distance at which each point is ensured at least one neighbour, and the matrix is row standardised (such 
that all elements in each row sum to one) to facilitate interpretation of the statistics47.
ethical clearance. Institutional Review Board approval was obtained from New York University, and 
Institutional Ethical Clearance from NIMR. Informed consent was obtained from all subjects or, if subjects were 
under 18, from a parent and/or legal guardian. All experiments were performed in accordance with the relevant 
guidelines and regulations.
Additional information. Supplementary information accompanies this paper. Data are available through 
the Clinical Epidemiology Database, ClinEpiD (https://clinepidb.org), part of the EuPathDB project49.
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